Federica Tomao

MRI- and Histologic-Molecular-Based Radio-Genomics Nomogram for Preoperative Assessment of Risk Classes in Endometrial Cancer

The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial

Metastatic Renal Cell Carcinoma Management: From Molecular Mechanism to Clinical Practice

Second-line Eribulin in Triple Negative Metastatic Breast Cancer patients. Multicentre Retrospective Study: The TETRIS Trial

PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world setting

Loss of HER2 and decreased T-DM1 efficacy in HER2 positive advanced breast cancer treated with dual HER2 blockade: the SePHER Study

Loss of HER2 and decreased T-DM1 efficacy in HER2 positive advanced breast cancer treated with dual HER2 blockade. The SePHER Study.

HER2 Nuclear Translocation and Decreased T-DM1 Efficacy in HER2 Positive Advanced Breast Cancer Treated with Dual HER2 Blockade. The SePHER Study.

Combined surgery and radiotherapy as curative treatment for tracheal adenoid cystic carcinoma: a case report

Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti‐HER2 agents in the real world setting

Early clear cell “sugar” lung cancer management: A case report and a brief literature review

Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor‐positive, advanced breast cancer: A real‐world experience

Innovazioni terapeutiche nel trattamento del tumore ovarico. Analisi del percorso per lo sviluppo terapeutico: dal platino all’immunoterapia

Targeting immune response with therapeutic vaccines in premalignant lesions and cervical cancer: hope or reality from clinical studies

“Triple positive” early breast cancer: an observational multicenter retrospective analysis of outcome

Prognostic role of inguinal lymphadenectomy in vulvar squamous carcinoma: younger and older patients should be equally treated. A prospective study and literature review

Chemotherapy-induced nausea and vomiting in Italian cancer centers: results of CINVDAY, a prospective, multicenter study.

Chemotherapy-Induced Nausea and Vomiting in Italian Cancer Centers: Results of CINVDAY, a Prospective, Multicenter Study

Circulating tumor cells in metastatic colorectal cancer: do we need an alternative cutoff?

An Update of Laparoscopy in Cervical Cancer Staging: Is It a Useful Procedure?

Malignant transformation of well‐differentiated papillary mesothelioma 13 years after the diagnosis: a case report

Factors influencing choice of chemotherapy in metastatic colorectal cancer (mCRC)

“Long extended” temozolomide in a selected population  with  not radically resected high-grade gliomas.